Chris Heberlig Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Chris Heberlig.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Chris Heberlig. Chris Heberlig is SVP, Finance & Business Ops. in SYNAGEVA BIOPHARMA CORP ($GEVA) and SVP, Finance and Business Ops. in SYNAGEVA BIOPHARMA CORP ($GEVA) and President and CFO in ORGANOVO HOLDINGS, INC. ($ONVO) and EVP & CFO in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and Exec VP & CFO in Kiniksa Pharmaceuticals, Ltd. ($KNSA).

Chris Heberlig in SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Chris Heberlig: SVP, Finance & Business Ops., SVP, Finance and Business Ops.
Holdings: 0 shares
Latest Transaction: Jun 23 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Chris Heberlig in SYNAGEVA BIOPHARMA CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, KNSA, ONVO, GEVA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	80.35	12,000	964,200	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	40.74	7,500	305,550	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	40.32	12,500	504,000	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	23.00	5,000	115,000	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	1.70	838	1,425	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Option Exercise	D	0.95	82	78	0
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Sell	D	0.00	24,000	0	0	24 K to 0 (-100.00 %)
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Sell	D	0.00	446	0	24,000	24.4 K to 24 K (-1.82 %)
Jun 23 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Grant	A	78.87	56	4,417	24,446	24.4 K to 24.4 K (+0.23 %)
Jun 09 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance & Busi ...	Grant	A	0.00	24,000	0	24,390	390 to 24.4 K (+6,153.85 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Option Exercise	M	40.74	7,500	305,550	7,500
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	105.74	300	31,722	390	690 to 390 (-43.48 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	104.57	1,510	157,901	690	2.2 K to 690 (-68.64 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	103.55	3,290	340,680	2,200	5.5 K to 2.2 K (-59.93 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	102.46	900	92,214	5,490	6.4 K to 5.5 K (-14.08 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	101.38	600	60,828	6,390	7 K to 6.4 K (-8.58 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Sell	S	100.44	900	90,396	6,990	7.9 K to 7 K (-11.41 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Buy	M	40.74	7,500	305,550	7,890	390 to 7.9 K (+1,923.08 %)
Mar 13 2015	GEVA	SYNAGEVA BIOPHARMA ...	Heberlig Chris	SVP, Finance and Bu ...	Grant	A	76.88	86	6,612	390	304 to 390 (+28.29 %)

Page: 1